Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HDI (Hypertension Diagnostics) issued key US patent:

This article was originally published in Clinica

Executive Summary

Hypertension Diagnostics (HDI) has gained what it claims is a significant US patent relating to the core technology in its cardiovascular profiling systems. The patent describes methods and apparatus for processing an arterial blood pressure waveform in order to extract clinically useful information regarding the state of the cardiovascular system. HDI's products can provide blood pressure values and non-invasively detect changes in the compliance or elasticity of large and small arteries. Changes in elasticity can indicate whether a patient has underlying vascular disease that might require further evaluation, says the St Paul, Minnesota firm.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT067413

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel